Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥10.5bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥18.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥9.1bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥1.7bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥1.2bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥1.8bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥2.5bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.3bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥1.8bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥1.3bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥1.2bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.6bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥848m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.2bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥926m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥30.1bnat 2023-09-30Cons.Assets
Total assets¥29.0bnat 2023-03-31Cons.Assets
Total assets¥27.5bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥7.5bnat 2023-09-30Cons.Liabilities
Total liabilities¥6.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥22.5bnat 2023-09-30Cons.Net assets
Net assets / equity¥22.1bnat 2023-03-31Cons.Net assets
Net assets / equity¥21.4bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥13.3bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥12.8bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥13.3bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥12.8bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥12.9bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥11.9bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥1.5bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.9bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥149m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥551m2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥232m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥985m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥500m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥486m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥155.762023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥100.272023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥214.782022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥110.62022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥67.942022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio71.0%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio72.4%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.7%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue2023-04-01 → 2023-09-30¥1.3bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.3bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentsegment profit2023-04-01 → 2023-09-30¥194m
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue2023-04-01 → 2023-09-30¥9.2bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue external2023-04-01 → 2023-09-30¥9.2bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentsegment profit2023-04-01 → 2023-09-30¥1.5bn
—segment totalrevenue2023-04-01 → 2023-09-30¥10.5bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥10.5bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥1.7bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentsegment profit2022-04-01 → 2022-09-30¥138m
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue2022-04-01 → 2022-09-30¥7.9bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue external2022-04-01 → 2022-09-30¥7.9bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentsegment profit2022-04-01 → 2022-09-30¥1.1bn
—segment totalrevenue2022-04-01 → 2022-09-30¥9.1bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥9.1bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥1.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 505
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember3350580
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.4137
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember679800
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.0839
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember462200
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0570
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember432900
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0534
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember115938
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0143
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember99296
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0122
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember70000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0086
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember58568
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0072
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember45994
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0056
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember45619
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0056
Number of shares heldCurrentQuarterInstant5360895
Shareholding ratioCurrentQuarterInstant0.6620
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember558700
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember8091300
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember80913
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember6780
Number of shares issued shares voting rightsCurrentQuarterInstant8656780
Number of voting rights issued shares voting rightsCurrentQuarterInstant80913
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member558700
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member558700
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0645
Number of shares held in own name treasury shares etcCurrentQuarterInstant558700
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant558700
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0645
Cash and depositsPrior1YearInstant12795930000JPY
Cash and depositsCurrentQuarterInstant13269917000JPY
Notes and accounts receivable tradePrior1YearInstant5160185000JPY
Notes and accounts receivable tradeCurrentQuarterInstant5591694000JPY
Short term investment securitiesPrior1YearInstant-JPY
Short term investment securitiesCurrentQuarterInstant1006113000JPY
Finished goodsPrior1YearInstant488000000JPY
Finished goodsCurrentQuarterInstant590957000JPY
Raw materials and suppliesPrior1YearInstant1089184000JPY
Raw materials and suppliesCurrentQuarterInstant1063322000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass